内蒙古医科大学学报
內矇古醫科大學學報
내몽고의과대학학보
Journal of Inner Mongolia Medical University
2014年
6期
517-521
,共5页
舒芬太尼%芬太尼%气管插管%内皮素%血栓素A2
舒芬太尼%芬太尼%氣管插管%內皮素%血栓素A2
서분태니%분태니%기관삽관%내피소%혈전소A2
sufentanil%fentanyl%trachea intubation%endothelin%thromboxanEA2
目的:探讨芬太尼与舒芬太尼在气管插管过程中对血浆内皮素( ET)、血栓素A2( TXA2)的影响及其意义。方法:将符合实验条件的60名择期全麻手术病人随机分为两组:芬太尼组(F组)和舒芬太尼组(S组),各30例。全麻诱导:F组静注咪唑安定0.05 mg/kg,芬太尼3.0μg/kg,异丙酚1.5 mg/kg,阿曲库铵0.15 mg/kg;S组将芬太尼替换为舒芬太尼0.4μg/kg,其余同F组。分别记录麻醉诱导前2 min( T1)、气管插管前即刻( T2)、插管后1 min( T3)、3 min( T4)、6 min( T5)和10 min( T6)病人的收缩压( SBP)、舒张压( DBP)和心率( HR),同时抽取静脉血,测定血浆ET和 TXA2含量。结果:F组气管插管后各时点 ET 和 TXA2含量明显高于基础值( P<0.05);S组气管插管后ET含量与基础值比较无显著变化(P>0.05),TXA2含量较基础值升高,但上升幅度明显小于F组,两组在气管插管后的四个时点ET、TXA2含量组间比较具有显著性差异(P<0.05)。结论:气管插管可引起机体血浆ET和TXA2含量的增加,与芬太尼相比,舒芬太尼能够更加有效地抑制ET、TXA2的合成与释放,对手术病人具有更好的保护作用。
目的:探討芬太尼與舒芬太尼在氣管插管過程中對血漿內皮素( ET)、血栓素A2( TXA2)的影響及其意義。方法:將符閤實驗條件的60名擇期全痳手術病人隨機分為兩組:芬太尼組(F組)和舒芬太尼組(S組),各30例。全痳誘導:F組靜註咪唑安定0.05 mg/kg,芬太尼3.0μg/kg,異丙酚1.5 mg/kg,阿麯庫銨0.15 mg/kg;S組將芬太尼替換為舒芬太尼0.4μg/kg,其餘同F組。分彆記錄痳醉誘導前2 min( T1)、氣管插管前即刻( T2)、插管後1 min( T3)、3 min( T4)、6 min( T5)和10 min( T6)病人的收縮壓( SBP)、舒張壓( DBP)和心率( HR),同時抽取靜脈血,測定血漿ET和 TXA2含量。結果:F組氣管插管後各時點 ET 和 TXA2含量明顯高于基礎值( P<0.05);S組氣管插管後ET含量與基礎值比較無顯著變化(P>0.05),TXA2含量較基礎值升高,但上升幅度明顯小于F組,兩組在氣管插管後的四箇時點ET、TXA2含量組間比較具有顯著性差異(P<0.05)。結論:氣管插管可引起機體血漿ET和TXA2含量的增加,與芬太尼相比,舒芬太尼能夠更加有效地抑製ET、TXA2的閤成與釋放,對手術病人具有更好的保護作用。
목적:탐토분태니여서분태니재기관삽관과정중대혈장내피소( ET)、혈전소A2( TXA2)적영향급기의의。방법:장부합실험조건적60명택기전마수술병인수궤분위량조:분태니조(F조)화서분태니조(S조),각30례。전마유도:F조정주미서안정0.05 mg/kg,분태니3.0μg/kg,이병분1.5 mg/kg,아곡고안0.15 mg/kg;S조장분태니체환위서분태니0.4μg/kg,기여동F조。분별기록마취유도전2 min( T1)、기관삽관전즉각( T2)、삽관후1 min( T3)、3 min( T4)、6 min( T5)화10 min( T6)병인적수축압( SBP)、서장압( DBP)화심솔( HR),동시추취정맥혈,측정혈장ET화 TXA2함량。결과:F조기관삽관후각시점 ET 화 TXA2함량명현고우기출치( P<0.05);S조기관삽관후ET함량여기출치비교무현저변화(P>0.05),TXA2함량교기출치승고,단상승폭도명현소우F조,량조재기관삽관후적사개시점ET、TXA2함량조간비교구유현저성차이(P<0.05)。결론:기관삽관가인기궤체혈장ET화TXA2함량적증가,여분태니상비,서분태니능구경가유효지억제ET、TXA2적합성여석방,대수술병인구유경호적보호작용。
Objective:To observe the effect of fentanyl and sufentanil on plasma endothelin( ET)、thromboxaneA2 ( TXA2 ) in the process of trachea intubation and provide reference for reasonable patients selection of narcotic analgesic. Methods:60 undergoing selective operation and according with our experiment qualification were divided into two groups, fentanyl group ( group F, n = 30 ) and sufentanil group(group S,n=30),30 cases in each group. General anesthesia induction:In group F,in-travenous injected midazolam 0. 05 mg/kg,fentanyl 3. 0μg/kg,prop ofol 1. 5 mg/kg,atracurium 0. 15 mg/kg·In group S,intravenous injected midazolam 0. 05 mg/kg,sufentanil 0. 4μg/kg,propofol 1. 5 mg/kg,atracurium 0.15 mg/kg·Six points of time were set up:2 minutes before induction(T1), before trachea intubation(T2),1 minute(T3)、3 minutes(T4)、6 minutes(T5)、10 minutes(T6)after trachea intubation. At these six points of time, we monitored and recorded systolic blood pressure (SBP),diastolic blood pressure(DBP),heart rate(HR)and drew venous blood to detect the contents of ET and TXA2 by radio-immunity method. Results:In group F,the content of ET and TXA2 at every point of time after trachea intubation were higher significantly than 2 minutes before induction ( P<0. 05),In group S,ET did not change obviously and TXA2 increased after trachea intubation. Between the two groups, the contents of ET and TXA2 at four points of time after trachea intubation were different significantly(P<0. 05). Conclusions:the contents of ET and TXA2 increase obviously in the process of trachea intubation, sufentanil can significantly restrain the production of ET、TXA2 in the process of trachea intubation and. protect the patients better.